advertisement
Barton K 24
Showing records 1 to 24 | Display all abstracts from Barton K106475 A simple surgical solution for the treatment of persistent postoperative hypotony after PRESERFLO MicroShunt implantation
Aguilar-Munoa S
Eye 2023; 37: 2126-2129
106751 Preserflo microshunt implant for the treatment of refractory uveitic glaucoma: 36-month outcomes
Triolo G
Eye 2023; 37: 2535-2541
105797 Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension
Gazzard G
Ophthalmology 2023; 130: 139-151
106588 Will the PRESERFLO™ MicroShunt impact the future of trabeculectomy practice? A UK and Éire Glaucoma Society National Survey
Kuet ML
Eye 2022; 0: 1-5
105992 Differences in the Surgical Outcomes of Glaucoma Surgery in Patients of African Caribbean Descent
Nagar AM
Current Eye Research 2022; 47: 1567-1577
106751 Preserflo microshunt implant for the treatment of refractory uveitic glaucoma: 36-month outcomes
Wang J
Eye 2023; 37: 2535-2541
105992 Differences in the Surgical Outcomes of Glaucoma Surgery in Patients of African Caribbean Descent
Maghsoudlou P
Current Eye Research 2022; 47: 1567-1577
106588 Will the PRESERFLO™ MicroShunt impact the future of trabeculectomy practice? A UK and Éire Glaucoma Society National Survey
Azuara-Blanco A
Eye 2022; 0: 1-5
105797 Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension
Konstantakopoulou E
Ophthalmology 2023; 130: 139-151
106475 A simple surgical solution for the treatment of persistent postoperative hypotony after PRESERFLO MicroShunt implantation
Tham YH
Eye 2023; 37: 2126-2129
105992 Differences in the Surgical Outcomes of Glaucoma Surgery in Patients of African Caribbean Descent
Wormald R
Current Eye Research 2022; 47: 1567-1577
106751 Preserflo microshunt implant for the treatment of refractory uveitic glaucoma: 36-month outcomes
Aguilar-Munoa S
Eye 2023; 37: 2535-2541
105797 Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension
Garway-Heath D
Ophthalmology 2023; 130: 139-151
106588 Will the PRESERFLO™ MicroShunt impact the future of trabeculectomy practice? A UK and Éire Glaucoma Society National Survey
Barton K
Eye 2022; 0: 1-5
106475 A simple surgical solution for the treatment of persistent postoperative hypotony after PRESERFLO MicroShunt implantation
Barton K
Eye 2023; 37: 2126-2129
106751 Preserflo microshunt implant for the treatment of refractory uveitic glaucoma: 36-month outcomes
Jayaram H
Eye 2023; 37: 2535-2541
105797 Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension
Adeleke M
Ophthalmology 2023; 130: 139-151
105992 Differences in the Surgical Outcomes of Glaucoma Surgery in Patients of African Caribbean Descent
Barton K
Current Eye Research 2022; 47: 1567-1577
106588 Will the PRESERFLO™ MicroShunt impact the future of trabeculectomy practice? A UK and Éire Glaucoma Society National Survey
King AJ
Eye 2022; 0: 1-5
106751 Preserflo microshunt implant for the treatment of refractory uveitic glaucoma: 36-month outcomes
Barton K
Eye 2023; 37: 2535-2541
105992 Differences in the Surgical Outcomes of Glaucoma Surgery in Patients of African Caribbean Descent
Hysi P
Current Eye Research 2022; 47: 1567-1577
105797 Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension
Vickerstaff V; Ambler G
Ophthalmology 2023; 130: 139-151
105992 Differences in the Surgical Outcomes of Glaucoma Surgery in Patients of African Caribbean Descent
Lim KS
Current Eye Research 2022; 47: 1567-1577
105797 Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension
Hunter R; Bunce C; Nathwani N; Barton K;
Ophthalmology 2023; 130: 139-151
